Patents by Inventor Indranil Adhya

Indranil Adhya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250368684
    Abstract: The present invention relates to a peptide of 12 to 30 amino acids, said peptide comprising the sequence SEQ ID NO: 1 represented by: (SEQ?ID?NO:?1) V-X1-X2-R-X3-E-W-X4-X5-X6-Y-W, wherein each of X1, X2, X3, X4, X5, and X6 independently corresponds to any amino acid, and wherein said peptide binds to the EGF receptor variant III (EGFRvIII), as well as products incorporating such peptide and uses thereof.
    Type: Application
    Filed: December 22, 2022
    Publication date: December 4, 2025
    Applicant: NANOTHERA BIOSCIENCES, INC.
    Inventors: Sourour MANSOUR, Coralie LEBLEU, Gauthier ERRASTI, Thomas DELACROIX, Raj CHAKRABARTI, Indranil ADHYA, Rama Krishna DUMPATI
  • Patent number: 12215069
    Abstract: In one aspect, compounds modulating sirtuin activity are described herein. Sirtuin modulation by compounds described herein includes sirtuin activation and sirtuin inhibition. Modulation of sirtuin activity includes sirtuin activation and/or sirtuin inhibition. In some embodiments, a sirtuin modulating compound and/or salt thereof is of Formula I described herein.
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: February 4, 2025
    Assignee: CODAGEN BIOSCIENCES, INC.
    Inventors: Célina Reverdy, Gaetan Gitton, Xiangying Guan, Indranil Adhya, Rama Krishna Dumpati, Samir Roy, Santu Chall, Anisha Ghosh, Gauthier Errasti, Thomas Delacroix, Raj Chakrabarti
  • Publication number: 20240228432
    Abstract: In one aspect, compounds modulating sirtuin activity are described herein. Sirtuin modulation by compounds described herein includes sirtuin activation and sirtuin inhibition. Modulation of sirtuin activity includes sirtuin activation and/or sirtuin inhibition. In some embodiments, a sirtuin modulating compound and/or salt thereof is of Formula I described herein.
    Type: Application
    Filed: January 24, 2024
    Publication date: July 11, 2024
    Inventors: Célina REVERDY, Gaetan GITTON, Xiangying GUAN, Indranil ADHYA, Rama Krishna DUMPATI, Samir ROY, Santu CHALL, Anisha GHOSH, Gauthier ERRASTI, Thomas DELACROIX, Raj CHAKRABARTI
  • Publication number: 20240228431
    Abstract: In one aspect, compounds modulating sirtuin activity are described herein. Sirtuin modulation by compounds described herein includes sirtuin activation and sirtuin inhibition. Modulation of sirtuin activity includes sirtuin activation and/or sirtuin inhibition. In some embodiments, a sirtuin modulating compound and/or salt thereof is of Formula I described herein.
    Type: Application
    Filed: December 29, 2022
    Publication date: July 11, 2024
    Inventors: Célina Reverdy, Gaetan Gitton, Xiangying Guan, Indranil Adhya, Rama Krishna Dumpati, Samir Roy, Santu Chall, Anisha Ghosh, Gauthier Errasti, Thomas Delacroix, Raj Chakrabarti
  • Patent number: 12012370
    Abstract: In one aspect, compounds modulating sirtuin activity are described herein. Sirtuin modulation by compounds described herein includes sirtuin activation and sirtuin inhibition. Modulation of sirtuin activity includes sirtuin activation and/or sirtuin inhibition. In some embodiments, a sirtuin modulating compound and/or salt thereof is of Formula I described herein.
    Type: Grant
    Filed: December 29, 2022
    Date of Patent: June 18, 2024
    Assignee: CODAGEN BIOSCIENCES, INC.
    Inventors: Célina Reverdy, Gaetan Gitton, Xiangying Guan, Indranil Adhya, Rama Krishna Dumpati, Samir Roy, Santu Chall, Anisha Ghosh, Gauthier Errasti, Thomas Delacroix, Raj Chakrabarti